A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
07 2023
Historique:
revised: 24 02 2023
received: 03 01 2023
accepted: 05 03 2023
medline: 14 7 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

A successful living donor liver transplant (LDLT) is the culmination of a multifaceted process coordinated among key stakeholders. We conducted an electronic survey of US liver transplant (LT) centers (August 26, 2021-October 10, 2021) regarding attitudes, barriers, and facilitators of LDLT to learn how to expand LDLT safely and effectively in preparation for the American Society of Transplantation Living Donor Liver Transplant Consensus Conference. Responses were received from staff at 58 programs (40.1% of US LT centers). There is interest in broadening LDLT (100% of LDLT centers, 66.7% of non-LDLT centers) with high level of agreement that LDLT mitigates donor shortage (93.3% of respondents) and that it should be offered to all suitable candidates (87.5% of respondents), though LDLT was less often endorsed as the best first option (29.5% of respondents). Key barriers at non-LDLT centers were institutional factors and surgical expertise, whereas those at LDLT centers focused on waitlist candidate and donor factors. Heterogeneity in candidate selection for LDLT, candidate reluctance to pursue LDLT, high donor exclusion rate, and disparities in access were important barriers. Findings from this study may help guide current and future expansion of LDLT more efficiently in the US. These efforts require clear and cohesive messaging regarding LDLT benefits, engagement of the public community, and dedicated resources to equitably increase LDLT access.

Identifiants

pubmed: 36938716
doi: 10.1111/ctr.14967
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14967

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Olthoff KM, Smith AR, Abecassis M, et al. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg. 2015;262(3):465-475. discussion 473-5. doi:10.1097/SLA.0000000000001383
Organ Procurement and Transplantation Network. Advanced Data Report Builder. Accessed at: Last Accessed March 27, 2022. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/
Lentine KL, Tanaka T, Xiao H, et al. Variation in adult living donor liver transplantation in the united states: identifying opportunities for increased utilization. Clin Transplant. 2023:e14924. doi:10.1111/ctr.14924
Rela M, Rammohan A. Why are there so many liver transplants from living donors in Asia and so few in Europe and the US? J Hepatol. 2021;75(4):975-980. doi:10.1016/j.jhep.2021.05.036
Kwong AJ, Ebel NH, Kim WR, et al. OPTN/SRTR 2020 annual data report: liver. Am J Transplant. 2022;22(2):204-309. doi:10.1111/ajt.16978. Suppl.
Declaration of Istanbul on organ trafficking and transplant tourism. Accessed Last Accessed March 27, 2022. https://www.declarationofistanbul.org/the-declaration
Kaplan A, Rosenblatt R, Jackson W, Samstein B. Practices and perceptions of living donor liver transplantation, nondirected donation, and liver paired exchange: a national survey. Liver Transpl. 2022;28(5):774-781. doi:10.1002/lt.26384
Emamaullee J, Conrad C, Kim M, et al. Assessment of the global practice of living donor liver transplantation. Transpl Int. 2021;34(10):1914-1927. doi:10.1111/tri.13960
Bittermann T, Abt PL, Olthoff KM, Kaur N, Heimbach JK, Emamaullee J. Impact of advanced renal dysfunction on posttransplant outcomes after living donor liver transplantation in the United States. Transplantation. 2021;105(12):2564-2570. doi:10.1097/TP.0000000000003728
Waterman AD, Morgievich M, Cohen DJ, et al. Living donor kidney transplantation: improving education outside of transplant centers about live donor transplantation-recommendations from a consensus conference. Clin J Am Soc Nephrol. 2015;10(9):1659-1669. doi:10.2215/CJN.00950115
Hunt HF, Rodrigue JR, Dew MA, et al. Strategies for increasing knowledge, communication, and access to living donor transplantation: an evidence review to inform patient education. Curr Transplant Rep. 2018;5(1):27-44. doi:10.1007/s40472-018-0181-1
Joyce M, Durant L, Emre S, et al. Expansion of patient education programming regarding live donor liver transplantation via virtual group encounters during the COVID-19 pandemic. Transplant Proc. 2021;53(4):1105-1111. doi:10.1016/j.transproceed.2021.01.038
Fox AN, Liapakis A, Batra R, et al. The use of nondirected donor organs in living donor liver transplantation: perspectives and guidance. Hepatology. 2022;75(6):1579-1589. doi:10.1002/hep.32260
Soin AS, Chaudhary RJ, Pahari H, Pomfret EA. A worldwide survey of live liver donor selection policies at 24 centers with a combined experience of 19 009 adult living donor liver transplants. Transplantation. 2019;103(2):e39-e47. doi:10.1097/TP.0000000000002475

Auteurs

AnnMarie Liapakis (A)

Department of Medicine, Yale University, New Haven, Connecticut, USA.

Uchenna Agbim (U)

Saint Louis University Center for Abdominal Transplantation, St. Louis, Missouri, USA.

Therese Bittermann (T)

University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Mary Amanda Dew (MA)

University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Yanhong Deng (Y)

Yale Center for Analytical Sciences, New Haven, Connecticut, USA.

Geliang Gan (G)

Yale Center for Analytical Sciences, New Haven, Connecticut, USA.

Sukru Emre (S)

Ege University School of Medicine, Izmir, Turkey.

Heather F Hunt (HF)

United Network for Organ Sharing, Richmond, Virginia, USA.

Kim M Olthoff (KM)

University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Jayme E Locke (JE)

University of Alabama, Birmingham, Alabama, USA.

Michelle T Jesse (MT)

Henry Ford Transplant Institute, Detroit, Michigan, USA.

Vineeta Kumar (V)

University of Alabama, Birmingham, Alabama, USA.

Anjana Pillai (A)

Department of Medicine, University of Chicago Medicine, Chicago, Illinois, USA.

Elizabeth Verna (E)

Center for Liver Disease and Transplantation, Columbia University, New York, New York, USA.

Krista L Lentine (KL)

Saint Louis University Center for Abdominal Transplantation, St. Louis, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH